Atjaunināt sīkdatņu piekrišanu

Lyme Disease: An Evidence-based Approach 2nd edition [Hardback]

Edited by (Overlook Medical Center, USA), Contributions by , Contributions by , Contributions by (Oslo University Hospital, Norway), Contributions by (New York Medical College, Valhalla, New York, UNIT), Contributions by (University of California Irvine, USA), Contributions by , Contributions by (John Hopkins University School, USA), Contributions by (American Lyme Disease Foundation), Contributions by
  • Formāts: Hardback, 298 pages, height x width x depth: 244x172x25 mm, weight: 921 g
  • Izdošanas datums: 20-Aug-2018
  • Izdevniecība: CABI Publishing
  • ISBN-10: 1786392070
  • ISBN-13: 9781786392077
Citas grāmatas par šo tēmu:
  • Formāts: Hardback, 298 pages, height x width x depth: 244x172x25 mm, weight: 921 g
  • Izdošanas datums: 20-Aug-2018
  • Izdevniecība: CABI Publishing
  • ISBN-10: 1786392070
  • ISBN-13: 9781786392077
Citas grāmatas par šo tēmu:
This new edition of Lyme Disease provides up-to-date evidence-based research and covers the significant advances in our understanding of the disorders referred to as Lyme disease or Lyme borreliosis. This book explores the causative organism, its requisite ecosystem, disease epidemiology, host-Borrelia interactions, diagnostic testing, clinical manifestations, therapeutic options, the role of host immunity on pathogenesis and long term prognosis. The authors provide balanced perspectives on all aspects of Lyme disease and explicitly review both the basic biology of the infection and practical clinical aspects.

Presented in full color throughout, this edition:

- Includes new borrelial pathogens that have been identified (B. miyamotoi, B. mayonii and B. bavariensis among others).
- Provides updated information on the molecular biology of the organism, neuroborreliosis, and the role of the C6 peptide in diagnosis.
- Discusses the controversies about "chronic Lyme disease," post Lyme disease syndrome and other ongoing but non-specific symptoms that have been attributed to this infection.

As the endemic footprint of Lyme disease continues to grow, this book provides a broad and detailed guide for clinicians and researchers involved with the diagnosis and treatment of the condition. Covering biology, epidemiology and therapeutics, it is also essential reading for students of global health and infectious disease.

Papildus informācija

Suitable for physicians and researchers involved in the diagnosis and treatment of Lyme disease.
Contributors vii
Preface to First Edition ix
Preface to Second Edition xi
PART I BIOLOGICAL SUBSTRATE
1 Ticks: The Vectors of Lyme Disease
1(28)
Robert P. Smith
2 Biology of the Lyme Disease Agents: A Selective Survey of Clinical and Epidemiologic Relevance
29(16)
Alan G. Barbour
3 Borreliella: Interactions with the Host Immune System
45(13)
Kirk Sperber
Raymond J. Dattwyler
4 Diagnostic Testing for Lyme Disease
58(18)
Paul G. Auwaerter
5 Global Epidemiology of Borreliella burgdorferi Infections
76(17)
Paul S. Mead
PART II CLINICAL ASPECTS
6 Antibiotic Therapy for Infection Caused by Borrelia burgdorferi Sensu Lato
93(12)
Gary P. Wormser
7 Lyme Borreliosis: The European Perspective
105(19)
Franc Strle
Gerold Stanek
Klemen Strle
8 Lyme Neuroborreliosis: A European Perspective
124(15)
Rick Dersch
9 Medically Unexplained Symptoms and Lyme Neuroborreliosis -- Not the Same: A Study in an Endemic Area of Norway
139(3)
Erlend Roaldsnes
Randi Eikeland
Dag Berild
10 Erythema Migrans
142(26)
Robert B. Nadelman
Linden Hu
11 Lyme Carditis
168(12)
Jonathan R. Salik
David M. Dudzinski
12 The Musculoskeletal Manifestations of Lyme Disease (Infection with Borrelia burgdorferi)
180(22)
Leonard H. Sigal
13 Nervous System Involvement
202(14)
John J. Halperin
14 Lyme Disease in Children
216(11)
Eugene D. Shapiro
15 The Psychology of `Post-Lyme Disease Syndrome' and `Not Lyme'
227(20)
Afton L. Hassett
Leonard H. Sigal
16 Chronic Lyme Disease
247(15)
Adriana Marques
17 Lyme Disease: The Great Controversy
262(17)
John J. Halperin
Phillip Baker
Gary P. Wormser
Index 279
Educated at MIT and Harvard and received his clinical training at the University of Chicago and Massachusetts General Hospital. Currently Professor of Neurology and Medicine at New York's Mount Sinai School of Medicine, he began his career on the neurology faculty of SUNY Stony Brook, just as Lyme disease was being characterized. The multidisciplinary collaborative group there was able to substantially improve the knowledge base regarding this infection. An author or contributor to approximately 150 articles and chapters, Dr. Halperin lectures widely. He serves on the Guideline Development Subcommittee of the American Academy of Neurology, has been a long-standing examiner for the Neurology Board examination, and has been heavily involved in patient outcome improvement at Atlantic Health, the multihospital system in New Jersey where he now leads Neurosciences. Under his leadership, Overlook Hospital's Neuroscience program has rapidly become recognized as the state's best and busiest.